iLite® assays for the quantification of the potency and neutralizing antibody response to recombinant AAV vectors
Time: 1:00 pm
day: Track A - Day 1 PM
Details:
- Highly sensitive assays, with an extended dynamic range,
have been developed based on the iLite® reporter-gene
technology for the quantification of the potency of AAV
encoded transgenes regulated by photoreceptor-specific
promoters without the need for helper virus or proteosome
inhibitors. - A highly sensitive, rapid, and serotype specific assay for the
quantification of neutralizing antibodies to recombinant
AAV vectors based on the iLite® technology will also be
presented
